RxDoctor Payments Data

Melissa Tungare, NP

Nurse Practitioner · Charlotte, NCNPI 1457904575

Payments from drug & device makers

$2,741in general payments, 2019–2025

Across 137 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$476
  • Johnson & Johnson$417
  • Amgen$353
  • Boehringer Ingelheim$284
  • Heartflow, Inc.$251
  • Novartis$205
  • plus $755 from 14 others

What the payments were for

  • Food & beverage$2,741100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,741 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$32,208
Medicare patients
229
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis12$273,344
EliquisApixaban158$129,018
Repatha SureclickEvolocumab90$69,760
EntrestoSacubitril/Valsartan52$48,093
JardianceEmpagliflozin51$35,008
XareltoRivaroxaban37$27,506
Praluent PenAlirocumab39$19,596
CorlanorIvabradine Hcl11$6,731
BrilintaTicagrelor12$5,342
Ranolazine ErRanolazine15$2,545
Metoprolol Succinate185$1,914
Rosuvastatin Calcium109$874
Losartan Potassium73$710
Torsemide33$702
Ezetimibe44$544

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Eliquis$155$402,362170 claims
NovartisEntresto$205$48,09352 claims
Boehringer IngelheimJardiance$284$35,00851 claims
Johnson & JohnsonXarelto$417$27,50637 claims
AmgenCorlanor$353$6,73111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →